Affiliation:
1. Department of Pediatrics, College of Medicine, University of Florida, Gainesville 32610-0296.
Abstract
In a double-blind, prospective, randomized study, 108 college women with acute urinary tract infections were treated for 7 days with either loracarbef (LY163892) at 200 mg once daily (n = 53) or cefaclor at 250 mg three times daily (n = 55). The cure rates at 5 to 9 days after treatment in the loracarbef and cefaclor groups were 96 and 90%, respectively. Both loracarbef and cefaclor are safe, well tolerated, and effective in the treatment of urinary tract infections in women.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference28 articles.
1. Antibiotic susceptibility testing by a standardized single dose method;Bauer A. C. O.;Am. J. Clin. Pathol.,1966
2. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor;Bill N. J.;Antimicrob. Agents Chemother.,1977
3. Black H. R. K. A. Desante J. D. Wolny and G. L. Brier. 1988. Program Abstr. 28th Intersci. Conf. Antimicrob. Agents Chemother. abstr. 123.
4. In vitro activity and P-lactamase stability of Ly 163892;Cao C.;J. Antimicrob. Chemother.,1988
5. Colton T. 1974. Statistics in medicine 1st ed. p. 151-188. Little Brown & Co. Boston.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献